George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIL0A.L Regulatory News (IL0A)

  • There is currently no data for IL0A

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2017 Supervisory Review and Evaluation Process

21 Dec 2017 07:00

RNS Number : 9912Z
Permanent TSB Group Holdings PLC
21 December 2017
 

21 December 2017

 

PERMANENT TSB GROUP HOLDINGS PLC (the "Bank")

 

2017 Supervisory Review and Evaluation Process

 

 

The Bank has been notified by the European Central Bank of the outcome of its 2017 Supervisory Review and Evaluation Process ("SREP") which will be effective from 1 January 2018.

 

The decision requires that the Bank maintains a Common Equity Tier 1 ("CET 1") ratio of 9.825% and a Total Capital ratio of 13.325% until 31 December 2018 on a transitional basis.

 

The CET 1 ratio of 9.825% consists of a Pillar 1 Capital Requirements Regulation ("CRR") requirement of 4.50%, a Pillar 2 Requirement ("P2R") of 3.45% (unchanged from the current year) and a Capital Conservation Buffer ("CCB") of 1.875% (reflecting a further year's phase-in).

 

The Total Capital ratio of 13.325% consists of a Minimum Own Funds CET1 requirement of 9.825% and a Minimum Own Funds Tier 1 and Tier 2 requirement of 3.50%.

 

The 2017 SREP requirement compares to the Bank's transitional CET1 ratio of 17.5%[1] and a Total Capital ratio of 18.7%1 at 30 September 2017.

 

In addition, the 2017 SREP decision advises that the Bank is prohibited from paying out dividends to shareholders.

 

Separately, the Bank has recently been de-designated as an Other Systemically Important Institution ("O-SII") by the Central Bank of Ireland. As a result, the previously guided O-SII capital requirement of 0.50% by 2020 does not apply to the Bank.

 

Both the SREP capital requirements (including the prohibition on payment of dividends) and O-SII buffers are subject to annual review.

 

 

Capital Requirements

Effective From

1.1.2018 to 31.12.2018

Effective From

1.1.2017 to

31.12.2017

Pillar 1 CET 1

4.50%

4.50%

Pillar 2 Requirement (P2R)

3.45%

3.45%

Capital Conservation Buffer

1.875%

1.25%

Total CET 1 Requirement / Maximum Distributable Amount Trigger

9.825%

9.20%

Tier 1

1.50%

1.50%

Tier 2

2.00%

2.00%

Total Capital Requirement

13.325%

12.70%

 

 

 

Ends

 

For further information, please contact:

 

Eamonn Crowley

Chief Financial Officer

eamonn.crowley@permanenttsb.ie

+353 1 669 5354

Rajesh ManirajanHead of Investor Relationsrajesh.manirajan@permanenttsb.ie+353 1 669 5622

Ray GordonGordon MRMptsb@gordonmrm.ie+353 87 241 7373

 

 

Note on forward-looking information:

This Announcement contains forward-looking statements, which are subject to risks and uncertainties because they relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Group or the industry in which it operates, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements referred to in this paragraph speak only as at the date of this Announcement. The Group undertakes no obligation to release publicly any revision or updates to these forward-looking statements to reflect future events, circumstances, unanticipated events, new information or otherwise except as required by law or by any appropriate regulatory authority.

 


[1] Includes profits earned in Q3 2017 which is subject to regulatory approval.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STROKKDPABDDCBB
Date   Source Headline
8th Nov 20187:00 amRNSTrading Statement
5th Nov 20184:30 pmRNSDirectorate Change
31st Oct 20187:00 amRNSDirector Declaration
4th Oct 201810:38 amRNSDirector Declaration
3rd Oct 201811:00 amRNSDirectorate Change
30th Aug 20188:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSHalf-year Report
29th Aug 20187:00 amRNS2018 Half-Year Results Commentary
31st Jul 20182:15 pmRNSSale of Non Performing Loan Portfolio
27th Jul 20187:00 amRNSDirectorate Change
24th Jul 201811:13 amRNSDirectorate Change
24th Jul 201811:00 amRNSDirectorate Change
16th May 20185:43 pmRNSResult of AGM
16th May 20185:15 pmRNSDirectorate Change
16th May 20187:00 amRNSTrading Statement
13th Apr 20182:00 pmRNSNotice of AGM
6th Apr 20183:00 pmRNSCourt approval for cancellation of deferred shares
29th Mar 201811:34 amRNSAnnual Financial Report
14th Mar 20187:00 amRNS2017 Annual Results Commentary
14th Mar 20187:00 amRNSAnnual Financial Report
21st Dec 20177:00 amRNS2017 Supervisory Review and Evaluation Process
13th Dec 20175:40 pmRNSDirector Declaration
29th Nov 201712:00 pmRNSDirectorate Change
8th Nov 20177:00 amRNSTrading Statement
18th Aug 20173:00 pmRNSHolding(s) in Company
16th Aug 20173:00 pmRNSHolding(s) in Company
15th Aug 201711:00 amRNSHolding(s) in Company
8th Aug 20172:00 pmRNSHolding(s) in Company
27th Jul 201710:00 amRNSHalf-year Report
26th Jul 20177:00 amRNS2017 Half-Year Results Commentary
26th Jul 20177:00 amRNSHalf-year Report
8th Jun 20171:00 pmRNSHolding(s) in Company
6th Jun 20172:00 pmRNSHolding(s) in Company
1st Jun 20173:30 pmRNSHolding(s) in Company
1st Jun 20173:30 pmRNSHolding(s) in Company
10th May 20174:45 pmRNSConfirmation of Director Appointment
10th May 20174:45 pmRNSResult of AGM
10th May 20177:00 amRNSTrading Update
12th Apr 201710:00 amRNSNotice of AGM
3rd Apr 201710:00 amRNSAnnual Financial Report
31st Mar 201711:00 amRNSChairman Appointment Update/New Company Secretary
8th Mar 20177:00 amRNSAnnual Financial Report
8th Mar 20177:00 amRNSAnnual Financial Report Commentary
7th Mar 20172:00 pmRNSAppointment of Chairman
16th Feb 20172:00 pmRNSAppointment of Chief Financial Officer
10th Feb 201712:00 pmRNSHolding(s) in Company
21st Dec 20163:00 pmRNSSupervisory Review & Evaluation Process Update
13th Dec 20162:30 pmRNS2016 Supervisory Review and Evaluation Process
18th Nov 201610:00 amRNSCompletion of Asset Sale
10th Nov 20167:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.